|
|
|
|
|
|
|
|
|
|
|
|
|
| Dockets Entered
On June 23, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995S-0117
|
| Human Drugs Patent Term
Extension & New Patents
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of
Imported Food Shipments
|
|
| 2003D-0571
|
| Guidance for Industry on Drug
Substance; Chemistry, Manufacturing, and Controls Information
|
|
| 2003N-0076
|
| Food Labeling: Trans
Fatty Acids in Nutrition Labeling; Consumer research to consider possible
footnote statements
|
|
|
| 2003P-0274
|
| In re Tier 1 initial
Approval Program
|
|
|
| 2003P-0574
|
| Regulatory limit for
Listeria monocytogenes in ready-to-eat foods that do not support its
growth
|
|
|
| 2004D-0188
|
| Guidance for Industry
on Development and Use of Risk Minimization Action Plans
|
|
|
| 2004N-0086
|
| Diabetes: Targeting
Safe and Effective Prevention and Treatment; Public Meeting
|
|
|
| 2004N-0115
|
| Prescription Drug Importation
Study
|
|
|
| 2004N-0133
|
| Part 11, Electronic
Record; Electronic Signatures; Public Meeting
|
|
|
| 2004N-0221
|
| Medicare Prescription
Drug, Improvement, and Modernization Act of 2003 Section 107(f) b
|
|
|
| 2004P-0171
|
| Standards for 'Similarity'
or 'Sameness' of Biotechnology-Derived Products
|
|
|
| 1995S-0117
|
| Human Drugs Patent
Term Extension & New Patents
|
|
|
| LST
93
|
| List as of June 22,
2004
|
| Vol #:
|
| 7
|
|
|
| 2001P-0075
|
| Switch Status of
Emergency Contraceptives from Rx to OTC
|
|
|
| EC 802
|
| N/A
|
| Vol #:
|
| 163
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior
Notice of Imported Food Shipments
|
|
|
| EC 489
|
| Mrs. Pilar Guerrero
Roldan
|
| Vol #:
|
| 29
|
|
|
| EC 490
|
| Mr. Rob Pounds
|
| Vol #:
|
| 29
|
|
|
| EC
491
|
| Always Canadian, LLC
|
| Vol #:
|
| 29
|
|
|
| EC
492
|
| Alaska Marine Lines,Inc.
|
| Vol #:
|
| 29
|
|
|
| 2003D-0476
|
| Guidance for Industry
on Product Recalls, Including Removals and Corrections; Availability
|
|
|
| EC 4
|
| Mr. Steve Dotson
|
| Vol #:
|
| 1
|
|
|
| 2003D-0571
|
| Guidance for Industry
on Drug Substance; Chemistry, Manufacturing, and Controls Information
|
|
|
| EC
3
Attachment
|
| SCHWARZ PHARMA AG
|
| Vol #:
|
| 1
|
|
|
| 2003N-0076
|
| Food Labeling: Trans
Fatty Acids in Nutrition Labeling; Consumer research to consider possible
footnote statements
|
|
|
| EC 29
|
| none
|
| Vol #:
|
| 7
|
|
|
| EC 30
|
| Dr. Ted Labuza
|
| Vol #:
|
| 7
|
|
|
| EC 31
|
| Ms. Mary Jo Shank
|
| Vol #:
|
| 7
|
|
|
| EC 32
|
| Mr. Joseph Wetzel
|
| Vol #:
|
| 7
|
|
|
| EC 33
|
| Mrs. Elizabeth Dehart
|
| Vol #:
|
| 7
|
|
|
| EC
34
Attachment
|
| Frito-Lay, North America
|
| Vol #:
|
| 1
|
|
|
| EMC
228
|
| National Dairy Council
(NDC)
|
| Vol #:
|
| 7
|
|
|
| 2003P-0274
|
| In re Tier 1 initial
Approval Program
|
|
| | | | | | | | |
|
|
| EMC
40
|
| Abigail Alliance
|
| Vol #:
|
| 4
|
|
|
| 2003P-0574
|
| Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
|
|
|
| EMC 3
|
| C. Hornback
|
| Vol #:
|
| 2
|
|
|
| 2004D-0188
|
| Guidance for Industry on Development and Use of Risk Minimization Action Plans
|
|
|
| EMC
3
|
| CenterFIRST
|
| Vol #:
|
| 1
|
|
|
| 2004N-0086
|
| Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
|
|
|
| EMC 17
|
| I. Robinett,RN,BSN,CDE,CPT
|
| Vol #:
|
| 1
|
|
|
| EMC 18
|
| G. Lorenzi, RN, CDE
|
| Vol #:
|
| 1
|
|
|
| EMC 19
|
| G. Lorenzi, RN, CDE
|
| Vol #:
|
| 1
|
|
|
| EMC 20
|
| J. Byers
|
| Vol #:
|
| 1
|
|
|
| EMC 21
|
| S. Strosnider
|
| Vol #:
|
| 1
|
|
|
| EMC 22
|
| M. Schenk
|
| Vol #:
|
| 1
|
|
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
| EMC
21
|
| Pharmaceutical Security Institute (PSI)
|
| Vol #:
|
| 19
|
|
|
| EMC
22
|
| META Solutions, Inc.
|
| Vol #:
|
| 19
|
|
|
| 2004N-0133
|
| Part 11, Electronic Record; Electronic Signatures; Public Meeting
|
|
|
| EC
16
Attachment
|
| AstraZeneca plc
|
| Vol #:
|
| 1
|
|
|
| EC 17
|
| CRF inc.
|
| Vol #:
|
| 1
|
|
|
| EMC
40
|
| Syngenta Limited, Alderley Park
|
| Vol #:
|
| 4
|
|
|
| EMC
41
|
| PHT Corporation
|
| Vol #:
|
| 4
|
|
|
| 2004N-0221
|
| Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 107(f) b
|
|
|
| EMC 4
|
| T. Florence
|
| Vol #:
|
| 1
|
|
|
| EMC
5
|
| MINOPS ProjectJudith Taylor
|
| Vol #:
|
| 1
|
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
|
|
| EMC
1
|
| Biotechnology Industry Organization
(BIO)
|
| Vol #:
|
| 1
|
|